- Home
- HCTI vs PHIO Comparison
HCTI vs PHIO Comparison
Compare HCTI & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCTI
- PHIO
- Stock Information
- Founded
- HCTI 2020
- PHIO 2011
- Country
- HCTI United States
- PHIO United States
- Employees
- HCTI N/A
- PHIO N/A
- Industry
- HCTI Retail: Computer Software & Peripheral Equipment
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- HCTI Technology
- PHIO Health Care
- Exchange
- HCTI Nasdaq
- PHIO Nasdaq
- Market Cap
- HCTI 13.5M
- PHIO 12.1M
- IPO Year
- HCTI 2021
- PHIO N/A
- Fundamental
- Price
- HCTI $2.74
- PHIO $1.86
- Analyst Decision
- HCTI
- PHIO Strong Buy
- Analyst Count
- HCTI 0
- PHIO 3
- Target Price
- HCTI N/A
- PHIO $10.67
- AVG Volume (30 Days)
- HCTI 879.7K
- PHIO 8.1M
- Earning Date
- HCTI 11-14-2025
- PHIO 11-11-2025
- Dividend Yield
- HCTI N/A
- PHIO N/A
- EPS Growth
- HCTI N/A
- PHIO N/A
- EPS
- HCTI N/A
- PHIO N/A
- Revenue
- HCTI $11,866,000.00
- PHIO N/A
- Revenue This Year
- HCTI N/A
- PHIO N/A
- Revenue Next Year
- HCTI N/A
- PHIO N/A
- P/E Ratio
- HCTI N/A
- PHIO N/A
- Revenue Growth
- HCTI N/A
- PHIO N/A
- 52 Week Low
- HCTI $1.37
- PHIO $0.97
- 52 Week High
- HCTI $435.75
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- HCTI 49.40
- PHIO 29.87
- Support Level
- HCTI $2.61
- PHIO $2.08
- Resistance Level
- HCTI $3.14
- PHIO $2.17
- Average True Range (ATR)
- HCTI 0.18
- PHIO 0.25
- MACD
- HCTI -0.00
- PHIO -0.03
- Stochastic Oscillator
- HCTI 30.66
- PHIO 5.66
About HCTI Healthcare Triangle Inc.
Healthcare Triangle Inc is a healthcare information technology company focused on advancing industry-transforming solutions in the sectors of cloud services, data science, and professional and managed services for the healthcare and life sciences industry. The company reinforces healthcare progress through technology and extensive industry know-how. HTI supports healthcare providers and payors, hospitals, and Pharma Life Sciences organizations in their effort to improve health outcomes by enabling the adoption of new technologies, data enlightenment, business agility, and accelerated response to immediate business needs and competitive threats. It provides services under three operating segments: Software Services, Managed Services, and Support and Platform Services.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.